StockData
Senti Biosciences Holdings, Inc. logo

Senti Biosciences Holdings, Inc. (SNTI) stock

SNTINasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 4/30
$0.10−0.04 (-28.68%)

Close on Nov 17, 2026Market cap $3.02MP/E –Yield –

Earnings

Senti Biosciences's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.

Next report
Nov 12, 2026
Q3 FY2026 · estimated, after the close
Revenue, Q1 FY2026
$16.00K
EPS, Q1 FY2026
-$0.14
Latest guidance
None
No outlook given in releases

Quarterly results

Revenue and earnings per share from each of Senti Biosciences's earnings releases, newest first

QuarterReportedRevenueYoYEPSSource
Q3 FY2026ended Sep 30, 2026Nov 12, 2026Expected––––
Q2 FY2026ended Jun 30, 2026Jul 15, 2026before the open–––Release
Q1 FY2026ended Mar 31, 2026May 14, 2026before the open$16.00K–-$0.14Release
Q4 FY2025ended Dec 31, 2025Mar 27, 2026before the open–––Release
Q3 FY2025ended Sep 30, 2025Nov 13, 2025after the close––-$0.69Release
Q2 FY2025ended Jun 30, 2025Aug 7, 2025before the open–––Release
Q1 FY2025ended Mar 31, 2025Apr 28, 2025before the open–––Release
Q4 FY2024ended Dec 31, 2024Mar 20, 2025after the close––-$0.67Release
Q3 FY2024ended Sep 30, 2024Nov 14, 2024after the close––-$6.31Release
Q2 FY2024ended Jun 30, 2024Aug 13, 2024after the close––-$2.45Release
Q1 FY2024ended Mar 31, 2024May 9, 2024after the close––-$0.26Release
Q4 FY2023ended Dec 31, 2023Mar 21, 2024after the close––-$0.42Release

Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.

Guidance

Senti Biosciences has not given guidance in its releases

Many companies give their outlook only on the conference call or not at all. When Senti Biosciences puts a forecast in an earnings release, it is listed here with the exact sentence.

Press releases

Releases Senti Biosciences filed with the SEC as exhibits to Form 8-K or 6-K

  1. Results
  2. Results
  3. Results
  4. Results
  5. Results
  6. Update
  7. Update
  8. Results
  9. Results
  10. Update
  11. Update
  12. Results
  13. Results
  14. Results
  15. Results

See a number that looks wrong?